OTCMKTS:IPIX Innovation Pharmaceuticals (IPIX) Stock Price, News & Analysis → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free IPIX Stock Alerts $0.0042 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$0.0042▼$0.004250-Day Range$0.0042▼$0.017052-Week Range$0.00▼$0.02Volume1,400 shsAverage Volume750,926 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Innovation Pharmaceuticals alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Innovation Pharmaceuticals Stock (OTCMKTS:IPIX)Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.Read More IPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IPIX Stock News HeadlinesApril 10, 2024 | forbes.comInnovationRx: $90 Million To Make Drugs In SpaceMarch 25, 2024 | msn.comIndia's healthcare innovation market poised to double by 2028April 23, 2024 | WealthPress (Ad)The system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.February 29, 2024 | msn.comPharma company Jubilant Biosys plans to expand India footprint, to foray into new therapeutic areas, says CEO Giuliano PerfettiJanuary 4, 2024 | msn.comHealthcare & Pharma Outlook 2024: Companies to focus on quality, sustainability, and accessibility; Surge in R&D expectedDecember 25, 2023 | msn.com3 Stocks at the Forefront of Medical InnovationNovember 14, 2023 | morningstar.comInnovation Pharmaceuticals Inc IPIXNovember 14, 2023 | morningstar.comInnovation Pharmaceuticals Inc IPIXApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. November 5, 2023 | msn.comEU proposal may accelerate pharma innovation decline, industry group saysOctober 27, 2023 | msn.comHow CPI's latest project will help to digitally transform the pharma industrySeptember 26, 2023 | msn.comPharma Industry Should Prioritise R&D, Focus On Innovative Products: Union Health MinisterAugust 28, 2023 | finance.yahoo.comInnovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024August 2, 2023 | uk.investing.comCSPC Innovation Pharmaceutical Co Ltd Class A (300765)June 21, 2023 | finance.yahoo.comInnovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal DiseasesJune 5, 2023 | finance.yahoo.comInnovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration TestingMay 31, 2023 | finance.yahoo.comIPIX - Innovation Pharmaceuticals Inc.May 21, 2023 | msn.comFocus on pharma: Knowledge, drive and FDI has made Ireland a global hub of innovationMay 16, 2023 | msn.comPrestige Wealth, Innovation Beverage, Scripps Safe slash IPO sizesApril 17, 2023 | finance.yahoo.comInnovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature CommunicationsApril 4, 2023 | marketwatch.comAI in Pharmaceutical Market 2023 Size and Forecast to 2031April 1, 2023 | wsj.comCSPC Innovation Pharmaceutical Co. Ltd. AMarch 20, 2023 | bizjournals.comWVU Innovation adds 3 new tenantsMarch 15, 2023 | finance.yahoo.comInnovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic ResearchersFebruary 23, 2023 | finance.yahoo.comInnovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA SubmissionFebruary 17, 2023 | marketwatch.comHealth Supplement Market 2023 : Business Scenario, Corporate Profiles, Size and Dynamic Innovation by 2028February 17, 2023 | marketwatch.comActive Pharmaceutical Ingredients Market Report Historical, Current, and Projected Size, in terms of value 2028See More Headlines Receive IPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:IPIX CUSIPN/A CIK1355250 Webwww.cellceutix.com Phone(978) 921-4125FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Leo Ehrlich CPA (Age 66)Chairman, CEO, CFO, Principal Accounting Officer & Secretary Comp: $515.85kMs. Jane Harness M.S. (Age 56)MP, Senior Vice President of Clinical Sciences & Portfolio Management Comp: $275kMr. Jim BoeheimBusiness AdvisorKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors IPIX Stock Analysis - Frequently Asked Questions How have IPIX shares performed in 2024? Innovation Pharmaceuticals' stock was trading at $0.0049 at the beginning of 2024. Since then, IPIX shares have decreased by 14.3% and is now trading at $0.0042. View the best growth stocks for 2024 here. Are investors shorting Innovation Pharmaceuticals? Innovation Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 18,000 shares, a drop of 70.4% from the March 15th total of 60,900 shares. Based on an average daily trading volume, of 584,300 shares, the short-interest ratio is presently 0.0 days. View Innovation Pharmaceuticals' Short Interest. What other stocks do shareholders of Innovation Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Innovation Pharmaceuticals investors own include Vaxart (VXRT), Broadcom (AVGO), Fulcrum Therapeutics (FULC), VIVUS (VVUS), CytoDyn (CYDY), ServiceNow (NOW), Sorrento Therapeutics (SRNE), United Airlines (UAL), Heat Biologics (HTBX) and Micron Technology (MU). How do I buy shares of Innovation Pharmaceuticals? Shares of IPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IPIX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovation Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
